stock logo

100% Buy

ORCHID PHARMA Share Price

ORCHPHARMA

₹1,433.20+₹62.00 (4.52%) TodayLast updated on 26 Jul, 2024 | 15:58 IST
₹1,373.95₹1,459.70
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹6,978 Crs

Open

₹1,374.00

Close

₹1,371.20

Circuit range

₹1,719.80 - ₹1,146.60

Day range

₹1,373.95 - ₹1,459.70

Year range

₹432.05 - ₹1,459.70

Volume

2,38,444

Avg. traded

₹1,428.53

Revenue (12m)

₹819 Crs

ORCHID PHARMAOrchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

ORCHID PHARMA Key indicators

arrow

52 week high

₹1,459.70

52 week low

₹432.05

P/E ratio

71.89

P/B ratio

5.95

ROE

7.84%

ROCE

8.77%

Dividend yield

--

Debt/Equity ratio

0.45

EPS

13.54

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

15.58%

Net profit margin

8.3%

ROE

7.84%

ROA

4.77%

ROCE

8.77%

Learn more

ORCHID PHARMA Shareholder returns

arrow

1 day

+0.10%

1 week

+17.83%

1 month

+14.80%

3 months

+25.52%

1 year

+144.25%

3 years

+175.95%

5 years

+7517.78%

ORCHID PHARMA Share Price history

arrow
DayOpenCloseDay’s change
Thu, Jul 25 2024
₹1,355.00
₹1,371.20
+0.10%
Wed, Jul 24 2024
₹1,360.05
₹1,369.80
-0.44%
Tue, Jul 23 2024
₹1,410.00
₹1,375.90
-0.56%
Mon, Jul 22 2024
₹1,299.00
₹1,383.60
+6.59%
Fri, Jul 19 2024
₹1,165.60
₹1,298.05
+11.54%
Thu, Jul 18 2024
₹1,139.85
₹1,163.75
+2.10%
Tue, Jul 16 2024
₹1,128.00
₹1,139.85
+1.78%
Mon, Jul 15 2024
₹1,137.00
₹1,119.95
-0.87%

Shareholding info

arrow

Promoters (69.84%)

Mutual Funds (15.18%)

Retail and other (10.47%)

Foreign institutions-FII (1.96%)

Other domestic institutions (2.55%)

Promoters

Learn more

Frequently asked questions